Citadel Advisors
MDXH icon

Citadel Advisors’s MDxHealth MDXH Stock Holding History

Citadel Advisors’s Portfolio MDXH Stock Details MDXH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$137K Sell
59,634
-35,478
-37% -$120K ﹤0.01% 11759
2025
Q4 		$340K Buy
95,112
+46,174
+94% +$182K ﹤0.01% 9875
2025
Q3 		$228K Buy
48,938
+11,456
+31% +$35.2K ﹤0.01% 10974
2025
Q2 		$82.8K Buy
+37,482
New +$70.3K ﹤0.01% 11473
2025
Q1 		– Sell
-29,606
Closed -$70.2K – 15147
2024
Q4 		$70.2K Sell
29,606
-40,324
-58% -$82.4K ﹤0.01% 11964
2024
Q3 		$145K Buy
+69,930
New +$190K ﹤0.01% 10601
2023
Q3 		– Sell
-21,289
Closed -$72.6K – 14770
2023
Q2 		$72.6K Buy
+21,289
New +$77.8K ﹤0.01% 11349

Other funds holding MDXH

BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return
AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return
MP
MVM Partners Boston, Massachusetts $10.8M AUM 61.97% 1-Year Est. Return
PCM
Perkins Capital Management Wayzata, Minnesota $133M AUM 127.86% 1-Year Est. Return
SM
Samjo Management New York $231M AUM 13.04% 1-Year Est. Return
MBAM
Mink Brook Asset Management West Palm Beach, Florida $179M AUM 37.68% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Citadel Advisors's MDXH Position: Q1 2026 in Review

Citadel Advisors reduced its MDxHealth (MDXH) stake by 37% in Q1 2026, selling an estimated $120K and leaving 59,634 shares worth $137K. The position accounts for ﹤0.01% of the portfolio, ranked #11759.

Citadel Advisors first reported a position in MDXH in Q2 2023 and has held it in 7 quarters since. The position peaked at $340K in Q4 2025. 51 funds tracked by Wall St. Rank hold MDXH as of Q1 2026.

  • Citadel Advisors held 59,634 shares of MDxHealth worth $137K as of Q1 2026.
  • Citadel Advisors sold 35,478 MDxHealth shares in Q1 2026, an estimated $120K.
  • MDxHealth made up ﹤0.01% of Citadel Advisors's portfolio in Q1 2026, its #11759 holding.
  • Citadel Advisors first reported a position in MDxHealth in Q2 2023 and has held it in 7 quarters since.
  • Citadel Advisors's MDxHealth position peaked at $340K in Q4 2025.
  • 51 funds tracked by Wall St. Rank held MDxHealth as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.